Zusammenfassung
In der Chirurgie/Gefäßchirurgie werden zunehmend multimorbide Patienten therapiert. Zum perioperativen Management vor nichtkardialen Operationen wurde 2022 eine Leitlinie der europäischen Gesellschaft für Kardiologie publiziert. Die Handlungsempfehlungen, mit besonderem Augenmerk auf gefäßchirurgische Patienten, werden hier zusammengefasst.
Präoperativ soll das individuelle Patienten- und Operationsrisiko evaluiert werden. Basierend auf diesen Faktoren erfolgt ein entsprechendes Risikoassessment und die Patienten durchlaufen einen Diagnostikalgorithmus. Neu ist die Empfehlung kardiale Biomarker vor Mittel- und Hochrisikooperationen bei Patienten ab 65 Lebensjahre oder mit entsprechenden Risikofaktoren und Vorerkrankungen durchzuführen. So wird frühzeitig in einer Hochrisikopopulation eine perioperative myokardiale Schädigung diagnostiziert. Die entsprechende Therapie soll die perioperative Mortalität senken. Gerade in der Gefäßchirurgie stellen die Patienten mit ihren atherosklerotischen Grunderkrankungen als Multisystemerkrankung große Herausforderungen an die perioperative Therapie und Diagnostik.
Abstract
Patients with multimorbidities are increasingly being treated by surgery/vascular surgery. A guideline on perioperative management prior to non-cardiac surgery was published by the European Society of Cardiology in 2022. The recommendations, with a focus on vascular surgery patients, are summarised here.
The individual patient and surgical risk should be evaluated preoperatively. Based on these factors, a corresponding risk assessment is carried out and the patients undergo a diagnostic algorithm. A new recommendation is to screen cardiac biomarkers before medium- and high-risk operations in patients aged 65 or over, or with specific cardiovascular risk factors or diseases. Therefore, perioperative myocardial damage is diagnosed early in a high-risk population. The appropriate therapy should reduce perioperative mortality. In vascular surgery in particular, patients with underlying atherosclerotic disease represent major challenges for perioperative therapy and diagnostics.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00772-024-01102-y/MediaObjects/772_2024_1102_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00772-024-01102-y/MediaObjects/772_2024_1102_Fig2_HTML.png)
Literatur
Bevölkerungsstruktur_und_Bevölkerungsalterung#Der_Anteil_.C3.A4lterer_Menschen_nimmt_weiter_zu. In. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Archive
Weiser TG, Haynes AB, Molina G et al (2015) Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet 385(Suppl 2: S11. https://doi.org/10.1016/S0140-6736(15):60806–60806
Smilowitz NR, Gupta N, Guo Y et al (2018) Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery. Heart 104:1180–1186. https://doi.org/10.1136/heartjnl-2017-312391
Rammos C, Steinmetz M, Lortz J et al. Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy—A population-based study. Lancet Reg Health Eur 2021; 5: 100113. https://doi.org/10.1016/j.lanepe.2021.100113
Halvorsen S, Mehilli J, Cassese S et al (2022) ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J 2022(43):3826–3924. https://doi.org/10.1093/eurheartj/ehac270
Smilowitz NR, Berger JS. Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review. Jama 2020; 324: 279–290. https://doi.org/10.1001/jama.2020.7840
Antoniou GA, Chalmers N, Georgiadis GS et al (2013) A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 57:242–253. https://doi.org/10.1016/j.jvs.2012.07.038
Farber A, Menard MT, Conte MS et al (2022) Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med 387:2305–2316. https://doi.org/10.1056/NEJMoa2207899
Bradbury AW, Moakes CA, Popplewell M et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet 2023; 401: 1798–1809. https://doi.org/10.1016/s0140-6736(23)00462-2
Mullen MG, Michaels AD, Mehaffey JH et al. Risk Associated With Complications and Mortality After Urgent Surgery vs Elective and Emergency Surgery: Implications for Defining “Quality” and Reporting Outcomes for Urgent Surgery. JAMA Surg 2017; 152: 768–774. https://doi.org/10.1001/jamasurg.2017.0918
Gupta PK, Gupta H, Sundaram A et al (2011) Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 124:381–387. https://doi.org/10.1161/circulationaha.110.015701
Duceppe E, Parlow J, MacDonald P et al (2017) Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol 33:17–32. https://doi.org/10.1016/j.cjca.2016.09.008
Muthspiel M, Hillinger P, Alber H et al (2023) Empfehlung zum Einsatz kardialer Biomarker in der ESC-Leitlinie für perioperatives Management von Patient: innen bei nicht-kardiochirurgischen Operationen: Herausforderungen und Chancen. Gefässchirurgie 28:520–526
Walter J, du Fay de Lavallaz J, Koechlin L et al. Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study. Ann Intern Med 2020; 172: 175–185. https://doi.org/10.7326/m19-0080
Walter JE, Honegger U, Puelacher C et al (2018) Prospective Validation of a Biomarker-Based Rule Out Strategy for Functionally Relevant Coronary Artery Disease. Clin Chem 64:386–395. https://doi.org/10.1373/clinchem.2017.277210
Puelacher C, Lurati BG, Seeberger D et al (2018) Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization. Circulation 137:1221–1232. https://doi.org/10.1161/circulationaha.117.030114
Sazgary L, Puelacher C, Lurati BG et al (2020) Incidence of major adverse cardiac events following non-cardiac surgery. Eur Heart J Acute Cardiovasc Care 10:550–558. https://doi.org/10.1093/ehjacc/zuaa008
Thygesen K, Alpert JS, Jaffe AS et al (2018) Fourth Universal Definition of Myocardial Infarction. J Am Coll Cardiol 2018(72):2231–2264. https://doi.org/10.1016/j.jacc.2018.08.1038
Irfan A, Reichlin T, Twerenbold R et al (2013) Early diagnosis of myocardial infarction using absolute and relative changes in cardiac troponin concentrations. Am J Med 126(82):781–788.e7. https://doi.org/10.1016/j.amjmed.2013.02.031
Zhao BC, Liu WF, Deng QW et al (2020) Meta-analysis of preoperative high-sensitivity cardiac troponin measurement in non-cardiac surgical patients at risk of cardiovascular complications. Br J Surg 107:e81–e90. https://doi.org/10.1002/bjs.11305
Caruana BC, Jackson SM, Ngyuen KJ et al (2020) Systematic review and meta-analysis of postoperative troponin as a predictor of mortality and major adverse cardiac events after vascular surgery. J Vasc Surg 72(131):1132–1143.e1. https://doi.org/10.1016/j.jvs.2020.03.039
Mueller C, McDonald K, de Boer RA et al (2019) Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail 21:715–731. https://doi.org/10.1002/ejhf.1494
Hiatt WR, Fowkes FG, Heizer G et al (2017) Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. N Engl J Med 376:32–40. https://doi.org/10.1056/NEJMoa1611688
Gallino A, Aboyans V, Diehm C et al (2014) Non-coronary atherosclerosis. Eur Heart J 35:1112–1119. https://doi.org/10.1093/eurheartj/ehu071
Lurati Buse GAL, Puelacher C, Gualandro DM et al (2021) Association between self-reported functional capacity and major adverse cardiac events in patients at elevated risk undergoing noncardiac surgery: a prospective diagnostic cohort study. Br J Anaesth 126:102–110. https://doi.org/10.1016/j.bja.2020.08.041
Naylor R, Rantner B, Ancetti S et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. European Journal of Vascular and Endovascular Surgery 2023; 65: 7–111. https://doi.org/10.1016/j.ejvs.2022.04.011
Kikura M, Oikawa F, Yamamoto K et al (2008) Myocardial infarction and cerebrovascular accident following non-cardiac surgery: differences in postoperative temporal distribution and risk factors. J Thromb Haemost 6:742–748. https://doi.org/10.1111/j.1538-7836.2008.02948.x
Sonny A, Gornik HL, Yang D et al (2014) Lack of association between carotid artery stenosis and stroke or myocardial injury after noncardiac surgery in high-risk patients. Anesthesiology 121:922–929. https://doi.org/10.1097/aln.0000000000000438
Ballotta E, Renon L, Da Giau G et al (2005) Prospective randomized study on asymptomatic severe carotid stenosis and perioperative stroke risk in patients undergoing major vascular surgery: prophylactic or deferred carotid endarterectomy? Ann Vasc Surg 19:876–881. https://doi.org/10.1007/s10016-005-7718-3
Aboyans V, Ricco JB, Bartelink MEL et al (2018) Editor’s choice—2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 55:305–368. https://doi.org/10.1016/j.ejvs.2017.07.018
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Interessenkonflikt
J. D. Süss und M. Gawenda geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
![figure qr](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00772-024-01102-y/MediaObjects/772_2024_1102_Figqr_HTML.png?s=1)
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Süss, J.D., Gawenda, M. & „Kommission perioperative Medizin“ der Deutschen Gesellschaft für Gefäßchirurgie und Gefäßmedizin. Algorithmus der präoperativen kardiovaskulären Diagnostik vor gefäßmedizinischen Eingriffen. Gefässchirurgie 29, 217–224 (2024). https://doi.org/10.1007/s00772-024-01102-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00772-024-01102-y
Schlüsselwörter
- Perioperative Komplikationen
- Troponin T/I
- Risikoassessment
- Perioperative myokardiale Ischämie
- Diagnostikalgorithmus